Drug intelligence / Profile preview

Bidiol

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Bidiol is a branded cannabis-derived product containing cannabidiol (CBD), a non-intoxicating phytocannabinoid from Cannabis sativa that exerts anticonvulsant, analgesic, anti-inflammatory, anxiolytic, and neuroprotective effects through complex modulation of the endocannabinoid system and multiple non-cannabinoid targets. Cannabidiol displays low affinity for CB1 and CB2 cannabinoid receptors and instead acts as a negative allosteric modulator at CB1, an antagonist at the orphan G protein–coupled receptor GPR55, and a modulator of intracellular calcium flux and various neurotransmitter systems, including serotonin, dopamine, and GABAergic signaling, which together are thought to underlie its seizure‑reducing and symptom‑modifying activity in certain neurologic conditions.[3][5][9][10]

Brand names
Bidiol
02

Targets

CNR1 (Cannabinoid receptor 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)ADRA1A (α1A)GPR55 (G protein-coupled receptor 55)MOR (Mu opioid receptor)GABRR (GABA-A receptor subunit rho)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on Bidiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bidiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call